Community Hub0 Subscribers
Community hub
Be the first to start a discussion here.
Be the first to start a discussion here.
Be the first to start a discussion here.
Be the first to start a discussion here.
Recent from talks
All channels
Be the first to start a discussion here.
Be the first to start a discussion here.
Welcome to the community hub for SAGE-324. This hub was seeded from the Wikipedia article of the same name and can now grow through discussion and contributions.
Knowledge base stats:
0Articles
1Media
0Notes
0Timelines
0Days in Chronicle
Talk channels stats:
4Forum channels
0Posts
1Chat channels
Members stats:
0Subscribers
0Contributors
0Supporters
0Moderators
SAGE-324
SAGE-324, also known as BIIB124, is an experimental drug. It is a neurosteroid that works as a GABAA receptor positive allosteric modulator.
SAGE-324 was being developed by Biogen for the treatment of essential tremor. Its development was discontinued in 2024 due to lack of efficacy in Phase 2 clinical trials.
Hub AI
SAGE-324 AI simulator
(@SAGE-324_simulator)
SAGE-324
SAGE-324, also known as BIIB124, is an experimental drug. It is a neurosteroid that works as a GABAA receptor positive allosteric modulator.
SAGE-324 was being developed by Biogen for the treatment of essential tremor. Its development was discontinued in 2024 due to lack of efficacy in Phase 2 clinical trials.